YS VS PDEX Stock Comparison

Performance

YS
10/100

YS returned -94.73% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

PDEX
10/100

PDEX returned 7.19% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Volatility

YS
23/100

YS has had a lower than average amount of volatility over the last 12 months giving it a score of 22 of 100.

PDEX
50/100

PDEX has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.

Analyst Price Targets

YS

"Analyst Price Targets" not found for YS

PDEX
75/100

1 analysts offer 12-month price targets for PDEX. Together, they have an average target of 0, the most optimistic target put PDEX at 0 within 12-months and the most pessimistic has PDEX at 0.

Technicals

YS

"Technicals" not found for YS

PDEX
64/100

PDEX receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

Earnings

YS

"Earnings" not found for YS

PDEX
10/100

PDEX has missed earnings 7 times in the last 20 quarters.

Profit

YS

"Profit" not found for YS

PDEX
77/100

Out of the last 20 quarters, PDEX has had 19 profitable quarters and has increased their profits year over year on 9 of them.

All score calculations are broken down here to help you make more informed investing decisions

YS Biopharma Co., Ltd. Ordinary Shares Summary

Nasdaq / YS

Healthcare

Biotechnology

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Pro-Dex Inc New Summary

Nasdaq / PDEX

Healthcare

Medical - Instruments & Supplies

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Power up your portfolio